Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2022 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Podcast
  • Videos
  • Education
  • About
    • Vacancies

Tag: IMpower130

Immune-related adverse events are associated with efficacy of atezolizumab in patients with advanced NSCLC

Presented By
Dr Mark Socinski, AdventHealth Cancer Institute, FL, USA
Trial
Phase 3, IMpower130, IMpower132, IMpower150
Conference
ASCO 2021

12 August, 2021 22:02


Register to view our latest news directly from the conference and receive news notifications in your field.

Register Now
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy